136 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

NBIX

Neurocrine Biosciences
US$115.93-3.8%0.7%US$11.6bUS$168.72PE34.5xE29.3%n/a

SPRO

Spero Therapeutics
US$1.28-5.5%6.7%US$69.2mUS$7.50PE4xE20.3%n/a

SRPT

Sarepta Therapeutics
US$124.84-1.8%1.0%US$11.9bUS$194.36PE251.7xE44.1%n/a

CPRX

Catalyst Pharmaceuticals
US$19.95-6.6%67.1%US$2.4bUS$30.14PE34.7xE20.9%n/a

PAHC

Phibro Animal Health
US$22.10-1.4%77.8%US$893.9mUS$15.60PE370.5xE51.5%2.2%

TGTX

TG Therapeutics
US$23.33-7.7%166.0%US$3.3bUS$33.75PE35xE43.5%n/a

MEDP

Medpace Holdings
US$326.26-11.6%32.4%US$9.9bUS$397.25PE29.7xE13.5%n/a

AMPH

Amphastar Pharmaceuticals
US$47.88-4.4%1.2%US$2.3bUS$59.80PE14xE14.1%n/a

CORT

Corcept Therapeutics
US$43.285.8%31.2%US$4.4bUS$65.40PE36.2xE38.4%n/a

ABBV

AbbVie
US$191.90-0.9%26.0%US$337.8bUS$196.54PE64xE25.3%3.2%

OCUP

Ocuphire Pharma
US$1.30-10.7%-62.6%US$33.8mUS$16.75PS2.1xE59.7%n/a

BMY

Bristol-Myers Squibb
US$50.122.2%-13.8%US$101.3bUS$53.43PS2.2xE49.0%4.8%

HRMY

Harmony Biosciences Holdings
US$39.792.1%15.8%US$2.1bUS$44.88PE19.7xE34.5%n/a

ZYNE

Zynerba Pharmaceuticals
US$1.304.0%96.1%US$65.6mUS$1.26PB2.3xE67.2%n/a

ADMA

ADMA Biologics
US$19.44-1.5%449.2%US$4.5bUS$19.00PE130.2xE26.0%n/a

HALO

Halozyme Therapeutics
US$56.95-4.3%45.5%US$7.1bUS$61.10PE21.4xE22.0%n/a

XFOR

X4 Pharmaceuticals
US$0.66-6.7%-38.3%US$108.4mUS$4.05PE6.3xE-8.0%n/a

IVVD

Invivyd
US$1.04-14.8%-41.2%US$117.1mUS$8.65PS54.9xE70.4%n/a

ARDX

Ardelyx
US$6.366.2%57.4%US$1.4bUS$11.28PS7.1xE66.3%n/a

CTXR

Citius Pharmaceuticals
US$0.52-5.7%-25.3%US$93.3mUS$4.67PB1.1xE65.6%n/a

VCEL

Vericel
US$44.07-8.2%29.3%US$2.2bUS$57.14PE2738.6xE51.6%n/a

LGND

Ligand Pharmaceuticals
US$99.38-5.4%61.6%US$1.8bUS$124.00PE43.1xE25.6%n/a

KRYS

Krystal Biotech
US$178.41-3.3%51.3%US$5.2bUS$207.22PE48.4xE34.2%n/a

PNT

POINT Biopharma Global
US$12.500.2%75.1%US$1.3bUS$12.50PE13.8xE9.2%n/a
Page 1 of 6
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.